Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 49
1983 66
1984 49
1985 48
1986 56
1987 65
1988 63
1989 56
1990 53
1991 49
1992 59
1993 63
1994 46
1995 62
1996 71
1997 74
1998 83
1999 88
2000 183
2001 130
2002 108
2003 112
2004 124
2005 124
2006 123
2007 102
2008 114
2009 140
2010 141
2011 148
2012 130
2013 104
2014 88
2015 68
2016 81
2017 82
2018 108
2019 75
2020 94
2021 114
2022 90
2023 80
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

3,583 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial.
Mori R, Honda S, Gomi F, Tsujikawa A, Koizumi H, Ochi H, Ohsawa S, Okada AA; TENAYA and LUCERNE Investigators. Mori R, et al. Jpn J Ophthalmol. 2023 May;67(3):301-310. doi: 10.1007/s10384-023-00985-w. Epub 2023 Apr 11. Jpn J Ophthalmol. 2023. PMID: 37039948 Free PMC article. Clinical Trial.
Endovascular surgery in the field of ophthalmology.
Kadonosono K, Hayashi A, de Juan E Jr. Kadonosono K, et al. Jpn J Ophthalmol. 2021 Jan;65(1):1-5. doi: 10.1007/s10384-020-00776-7. Epub 2020 Nov 8. Jpn J Ophthalmol. 2021. PMID: 33161486 Review.
Sagging eye syndrome.
Goseki T. Goseki T. Jpn J Ophthalmol. 2021 Jul;65(4):448-453. doi: 10.1007/s10384-021-00839-3. Epub 2021 May 20. Jpn J Ophthalmol. 2021. PMID: 34014448 Review.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Meibomian Gland Dysfunction Clinical Practice Guidelines.
Amano S, Shimazaki J, Yokoi N, Hori Y, Arita R; Committee for Meibomian Gland Dysfunction Clinical Practice Guidelines. Amano S, et al. Jpn J Ophthalmol. 2023 Jul;67(4):448-539. doi: 10.1007/s10384-023-00995-8. Epub 2023 Jun 23. Jpn J Ophthalmol. 2023. PMID: 37351738 No abstract available.
What is glaucomatous optic neuropathy?
Nakazawa T, Fukuchi T. Nakazawa T, et al. Jpn J Ophthalmol. 2020 May;64(3):243-249. doi: 10.1007/s10384-020-00736-1. Epub 2020 May 12. Jpn J Ophthalmol. 2020. PMID: 32394134 Review.
Update on glial antibody-mediated optic neuritis.
Song H, Zhou H, Wei S. Song H, et al. Jpn J Ophthalmol. 2022 Sep;66(5):405-412. doi: 10.1007/s10384-022-00932-1. Epub 2022 Jul 27. Jpn J Ophthalmol. 2022. PMID: 35895155 Review.
3,583 results